Epstein Secrets

From: Boris Nikolic To: Jeffrey Epstein <[email protected]> Subject: FW: Foundation Medicine Files Registration Statement for Proposed Initial Public Offering of

From: Boris Nikolic To: Jeffrey Epstein <[email protected]> Sub

From: Boris Nikolic To: Jeffrey Epstein <[email protected]

sdiction. Contacts Media — Foundation Medicine Dan Budwick Pure Communications, Inc. or Investors — Foundation Medicine Matt Clawson, Source: Foundation Medicine, Inc. EFTA00676602 View this news release online at: ;Powered by Business Wire http://v.w.v.businesswire.cominews/home/20130729006496/en EFTA00676603

From: Boris Nikolic To: jeffrey E. <[email protected]> Subject: FW: Priority Health is First Health Plan to Cover FoundationOne@ and FoundationOne@ Heme to Enhanc

From: Boris Nikolic To: jeffrey E. <[email protected]> Subject:

From: Boris Nikolic To: jeffrey E. <[email protected]>

s CLIA-certified lab. Please visit www.FoundationOne.com for more information. Foundation Medicine@ and FoundationOne@ are registered trademarks of Foundation Medicine, Inc. About Priority Health Priority Health is an award-winning, Michigan-based non-profit health plan nationally recognized for improving the health an

ENT OF LETTER OF AGREEMENT REGARDING PURCHASE OF PARTNERSHIP INTEREST effective September 3, 2013 by and between William H. Gates ("Gates") and Dr. Boris Nikolic ("Dr. Nikolic") is made on and dated as of October 6.2015 ("Amendment"). WHEREAS, Gates and Dr. Nikolic entered into a certain Letter of Agreement R

EEMENT REGARDING PURCHASE OF PARTNERSHIP INTEREST effective September 3, 2013 by and between William H. Gates ("Gates") and Dr. Boris Nikolic ("Dr. Nikolic") is made on and dated as of October 6.2015 ("Amendment"). WHEREAS, Gates and Dr. Nikolic entered into a certain Letter of Agreement Regarding Purch

y and between William H. Gates ("Gates") and Dr. Boris Nikolic ("Dr. Nikolic") is made on and dated as o

ive September 3, 2013 (the "Letter Agreement"); and WHEREAS, while serving as an observer board member attending meetings the Board of Directors of Foundation Medicine, Inc. ("FMI"), lock-ups and other restrictions on transfer with respect to the securities of FMI which were imposed on members of FMI's Board of Directors

From: Boris Nikolic Sent: Thursday, March 20, 2014 10:11 PM To: J

From: Boris Nikolic Sent: Thursday, March 20, 2014 10:11 PM

From: Boris Nikolic Sent: Thursday, March 20, 2014 10:11 PM To: J

dici ne-persona li zed-cancer- ph=rmaceutical-ipo-fetches-1-billion-valuation?source=email_rt_mc_focus_2> by The Value Investor More News on FMI • Foundation Medicine, Inc. misses by $0.05, beats on revenue <http://emai Iseeki ngal pha .com:80/=rack?type=click&mai lingid=1638353&messageid=CM_2900&=3Bdataba seid=&seri a

valent to the information rights currently provided by FMI to Labcorp and Roche Ventures. Mike Pellini would be happy to discuss directly with you, Boris, John, Allan or others how these rights can effectively be managed to meet GV's expectations. Mike's numbers are as follows: office-617.418.2244 an

cationegmail.comueevacationifpgmail.cornj From: Boris Nikolic Sent Fri 7/5/2013 10:38:34 PM Subject: FW: Fou

egmail.comueevacationifpgmail.cornj From: Boris Nikolic Sent Fri 7/5/2013 10:38:34 PM Subject: FW: Fou

r team for all of your efforts. EFTA_R1_00447439 EFTA01967988 Best regards, --Bob Robert W. Hesslein Senior Vice President / General Counsel Foundation Medicine, Inc. This communication and any files transmitted with it may contain information that is considered to be confidential, privileged and exempt from disc

y CMS which will propel to the multiples of it current value. B From: Foundation Medicine, Inc. [mailt Sent: Tuesday, August 12, 2014 1:08 P To: Boris Nikolic Subject: Foundation Medicine Announces 2014 Second Quarter Results and Recent Highlights <http://www.foundationmedicine.com> Aug. 12, 2014 20:00 U

From: Boris Nikolic NIMMONS Sent: Tuesday, August 12, 2014 8:27 PM

From: Boris Nikolic NIMMONS Sent: Tuesday, August 12, 2014

likely at one point within next year a reimbursement decision will happened by CMS which will propel to the multiples of it current value. B From: Foundation Medicine, Inc. [mailt Sent: Tuesday, August 12, 2014 1:08 P To: Boris Nikolic Subject: Foundation Medicine Announces 2014 Second Quarter Results and Recent Highl

reement Regarding Purchase of Partnership Interest This letter sets forth the agreement by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we disc

rchase of Partnership Interest This letter sets forth the agreement by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we discussed potentia

een you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purc

5 EFTA01961313 - 40 - EFTA_R1_00436126 EFTA01961314 t ( 1 ( -41- EFTA_R1_00436127 EFTA01961315 - 41 - EFTA_R1_00436128 EFTA01961316 Foundation Medicine, Inc. and ResearchGate GmbH - 43 - EFTA_R1_00436129 EFTA01961317 44 EFTA_R1_00436130 EFTA01961318 - 45 - EFTA_R1_00436131 EFTA01961319 - 46 -

artnership Interest Effective September 3, 2013, this letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we dis

Effective September 3, 2013, this letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we discussed potenti

een you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purc

bH Investment Entity Payment Demands Gates, through one or more affiliated entities (the "Gates Purchaser"), has heretofore made an investment in Foundation Medicine, Inc., a Delaware corporation with principal offices located in Cambridge, Massachusetts ("Foundation Medicine"), in the amount of Ten Million Dollars (